Cambridge Investment Research Advisors
HCA icon

Cambridge Investment Research Advisors’s HCA Healthcare HCA Stock Holding History

Cambridge Investment Research Advisors’s Portfolio HCA Stock Details HCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.25M Buy
10,914
+1,571
+17% +$664K 0.01% 1128
2026
Q1 		$4.42M Sell
9,343
-1,283
-12% -$646K 0.01% 1033
2025
Q4 		$4.96M Sell
10,626
-206
-2% -$95.6K 0.01% 939
2025
Q3 		$4.62M Buy
10,832
+1,495
+16% +$579K 0.01% 961
2025
Q2 		$3.58M Sell
9,337
-381
-4% -$137K 0.01% 1049
2025
Q1 		$3.36M Sell
9,718
-248
-2% -$79.8K 0.01% 1028
2024
Q4 		$2.99M Buy
9,966
+610
+7% +$213K 0.01% 1098
2024
Q3 		$3.8M Sell
9,356
-957
-9% -$350K 0.01% 958
2024
Q2 		$3.31M Sell
10,313
-7,596
-42% -$2.47M 0.01% 974
2024
Q1 		$5.97M Buy
17,909
+9,001
+101% +$2.75M 0.02% 655
2023
Q4 		$2.41M Sell
8,908
-773
-8% -$191K 0.01% 1089
2023
Q3 		$2.38M Buy
9,681
+2,183
+29% +$597K 0.01% 1027
2023
Q2 		$2.28M Sell
7,498
-156
-2% -$43.4K 0.01% 1094
2023
Q1 		$2.02M Sell
7,654
-2,782
-27% -$707K 0.01% 1115
2022
Q4 		$2.5M Sell
10,436
-1,578
-13% -$353K 0.01% 960
2022
Q3 		$2.21M Buy
12,014
+2,580
+27% +$514K 0.01% 976
2022
Q2 		$1.58M Sell
9,434
-3,703
-28% -$796K 0.01% 1172
2022
Q1 		$3.29M Buy
13,137
+4,408
+50% +$1.11M 0.02% 862
2021
Q4 		$2.24M Sell
8,729
-236
-3% -$57.8K 0.01% 1075
2021
Q3 		$2.18M Buy
8,965
+128
+1% +$31.3K 0.01% 1056
2021
Q2 		$1.83M Buy
8,837
+677
+8% +$138K 0.01% 1172
2021
Q1 		$1.54M Sell
8,160
-229
-3% -$40.4K 0.01% 1160
2020
Q4 		$1.38M Sell
8,389
-295
-3% -$43.1K 0.01% 1126
2020
Q3 		$1.08M Buy
8,684
+238
+3% +$29.5K 0.01% 1146
2020
Q2 		$820K Sell
8,446
-4,943
-37% -$514K 0.01% 1247
2020
Q1 		$1.2M Buy
13,389
+391
+3% +$50.6K 0.01% 884
2019
Q4 		$1.92M Sell
12,998
-92
-0.7% -$12.4K 0.01% 811
2019
Q3 		$1.58M Sell
13,090
-308
-2% -$39.8K 0.01% 850
2019
Q2 		$1.81M Buy
13,398
+1,933
+17% +$244K 0.02% 756
2019
Q1 		$1.5M Buy
11,465
+4,630
+68% +$622K 0.01% 837
2018
Q4 		$851K Sell
6,835
-566
-8% -$76K 0.01% 1018
2018
Q3 		$1.03M Buy
7,401
+267
+4% +$33.2K 0.01% 1009
2018
Q2 		$732K Sell
7,134
-368
-5% -$37.2K 0.01% 1179
2018
Q1 		$728K Sell
7,502
-355
-5% -$34.4K 0.01% 1117
2017
Q4 		$690K Buy
7,857
+2,227
+40% +$179K 0.01% 1115
2017
Q3 		$448K Sell
5,630
-57
-1% -$4.58K 0.01% 1302
2017
Q2 		$496K Sell
5,687
-1,713
-23% -$145K 0.01% 1207
2017
Q1 		$659K Sell
7,400
-3,206
-30% -$267K 0.01% 939
2016
Q4 		$785K Sell
10,606
-25
-0.2% -$1.87K 0.01% 799
2016
Q3 		$804K Buy
10,631
+5,156
+94% +$395K 0.01% 785
2016
Q2 		$422K Sell
5,475
-361
-6% -$28.5K 0.01% 1015
2016
Q1 		$455K Buy
5,836
+855
+17% +$59.7K 0.01% 949
2015
Q4 		$337K Sell
4,981
-567
-10% -$39.6K 0.01% 1078
2015
Q3 		$429K Buy
5,548
+140
+3% +$12.4K 0.01% 832
2015
Q2 		$491K Buy
5,408
+2,705
+100% +$217K 0.01% 818
2015
Q1 		$203K Sell
2,703
-740
-21% -$53.1K 0.01% 1247
2014
Q4 		$253K Buy
+3,443
New +$242K 0.01% 1092

Other funds holding HCA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Cambridge Investment Research Advisors's HCA Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its HCA Healthcare (HCA) stake by 17% in Q2 2026, buying an estimated $664K and bringing the position to 10,914 shares worth $4.25M. The position accounts for 0.01% of the portfolio, ranked #1128.

Cambridge Investment Research Advisors first reported a position in HCA in Q4 2014 and has held it in 47 quarters since. The position peaked at $5.97M in Q1 2024. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Cambridge Investment Research Advisors held 10,914 shares of HCA Healthcare worth $4.25M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 1,571 HCA Healthcare shares in Q2 2026, an estimated $664K.
  • HCA Healthcare made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1128 holding.
  • Cambridge Investment Research Advisors first reported a position in HCA Healthcare in Q4 2014 and has held it in 47 quarters since.
  • Cambridge Investment Research Advisors's HCA Healthcare position peaked at $5.97M in Q1 2024.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.